FDA signs CRADA with CluePoints
Publié le
FDA signs CRADA with CluePoints to Explore Data-Driven Approach to Quality Oversight in Clinical Trials FDA and its stakeholders have an…
Publié le
FDA signs CRADA with CluePoints to Explore Data-Driven Approach to Quality Oversight in Clinical Trials FDA and its stakeholders have an…
Publié le
IDDI organized a webinar on the current use and potential of Health Technology Assessment (HTA) as a component of clinical trials…
Publié le
IDDI organized a webinar on the Current Status of Surrogates for Survival in Cancer Trials. VIEW THE RECORDING OF THE…
Publié le
IDDI organized a webinar on Personalized Cancer Medicine Needs Randomized Trials. Clinical cancer research is undergoing profound changes, mostly because…
Publié le
IDDI organized a webinar on Patient-Level Data Sharing in Clinical Research. Our experts from IDDI and GSK spoke about principles, opportunities,…
Publié le
IDDI organized a webinar on the analytical validation of in-vitro diagnostic devices entitled ‘From Biomarkers to In-vitro Companion Diagnostic Device :…
Publié le
IDDI organized a webinar on the Future of Cancer Clinical Trials. Cancer clinical trials have been a major determinant of…
Publié le
IDDI organized a webinar on Data Monitoring Committees (DMC) best practices. This webinar explored data monitoring committees (DMC) best practices…
Publié le
IDDI organized a webinar on Implementing Adaptive Trials: Operational Considerations. WATCH RECORDED WEBINAR TO ACCESS THE PRESENTATION OF THIS ON-DEMAND WEBINAR,…
Publié le
IDDI organized a webinar on Pros and Cons of Adaptive Designs. Topics included: Continual reassessment methods for phase I trials Adaptive…